$GSK

AI Analysis

Generated on May 11, 2026

AI Score
68/ 100
Hold$GSK

GSK plc

$GSKNYSEHealthcareLarge-Cap

GSK discovers and develops medicines and vaccines in infectious diseases, HIV, oncology, and immunology.

Market Cap
$75.0B
Revenue (TTM)
$37.5B
+5.0%
Net Income (TTM)
$6.0B
+8.0%
EPS (TTM)
$2.90
P/E Ratio
14.0
Dividend Yield
3.5%
52-Week Range
$33-$44
Beta
0.52
Dimension Scores
Fundamental
70
Technical
62
Sentiment
66
Risk / Reward
72
Momentum
58
FundTechSentRiskMome
Financial Health
Profitability
75moderate
Growth
61moderate
Liquidity
80strong
Solvency
72strong
Efficiency
68strong

Valuation, technical analysis, investment thesis, risk assessment and more for $GSK

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.